Mga Batayang Estadistika
| LEI | 549300Z8MHH8NUYXQ229 |
| CIK | 55529 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Kewaunee Scientific Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction (Commission (IRS. |
|
| August 27, 2025 |
Kewaunee Scientific Corporation Annual Shareholder Speech August 27, 2025 EX-99.2 Exhibit 99.2 ANNUAL SHAREHOLDER SPEECH AUG 27, 2025 Kewaunee Scientific Corporation Annual Shareholder Speech August 27, 2025 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee’s 2025 annual shareholder meeting. This year’s meeting is again being conducted virtually, providing our shareholders with a more accessible |
|
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 27, 2025 |
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026 Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| August 27, 2025 |
EX-99.1 Exhibit 99.1 KEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU Special Note Regarding Forward-Looking Statements Certain statements in this document constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the Reform Act ). All statements other than statements of historical fact included in this Annual Report, including statements regardi |
|
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 2, 2025 |
aried and Hourly Employees of Kewaunee Scientific Corporation effective January 1, 2025 Pre-Approved Defined Contribution Plan – 06/30/2020 PS Plan 42325-1743728688AA 2020 FMR LLC All rights reserved. |
|
| July 2, 2025 |
Section # 1.0 Subject # 70.00 KEWAUNEE SCIENTIFIC CORPORATION Corporate Procedures Manual SUBJECT: FEDERAL SECURITIES LAWS REGARDING MATERIAL INSIDE INFORMATION Page 1 of 4 Date Issued: 1/1/90 Date Revised: May 1, 2016 May 9, 2018 May 6, 2019 March 8, 2023 May 22, 2023 December 11, 2023 January 14, 2025 Date Effective: January 20, 2025 Revised By: . Approved By: . VP-Finance/CFO Corporate Secretar |
|
| July 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| July 2, 2025 |
Kewaunee Scientific Corporation Incentive-Based Compensation Recovery Policy 317077084.1 KEWAUNEE SCIENTIFIC CORPORATION INCENTIVE-BASED COMPENSATION RECOVERY POLICY EFFECTIVE DECEMBER 1, 2023 1. Policy Purpose. The purpose of this Kewaunee Scientific Corporation (the “Company”) Incentive-Based Compensation Recovery Policy (this “Policy”) is to enable the Company to recover Erroneously Awarded Compensation in the event that the Company is required to prepare an Accounting |
|
| July 2, 2025 |
` Exhibit 21.1 Name of Subsidiary Jurisdiction of Organization Percentage Ownership Nu Aire, Inc. United States 100% Kewaunee Labway Asia Pte. Ltd. Singapore 100% Kewaunee Labway India Pvt. Ltd. India 92% Kewaunee Scientific Corporation Singapore Pte. Ltd. Singapore 100% Koncepo Scientech International Pvt. Ltd. India 80% Kequip Global Lab Solutions Pvt. Ltd. India 70% |
|
| June 26, 2025 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| June 26, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| June 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| June 11, 2025 |
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report KEWAUNEE SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2700 West Front Street Statesville, North Carolina 286 |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| March 12, 2025 |
Kewaunee Scientific Announces Amendment to Share Repurchase Program Kewaunee Scientific Announces Amendment to Share Repurchase Program Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| March 12, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| March 12, 2025 |
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| February 26, 2025 |
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025 Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| February 26, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| January 16, 2025 |
NU AIRE, INC. FINANCIAL STATEMENTS YEARS ENDED SEPTEMBER 30, 2024 AND 2023 Exhibit 99.1 NU AIRE, INC. FINANCIAL STATEMENTS YEARS ENDED SEPTEMBER 30, 2024 AND 2023 NU AIRE, INC. TABLE OF CONTENTS YEARS ENDED SEPTEMBER 30, 2024 AND 2023 INDEPENDENT AUDITOR’S REPORT 3 FINANCIAL STATEMENTS BALANCE SHEETS 5 STATEMENTS OF INCOME AND RETAINED EARNINGS 7 STATEMENTS OF CASH FLOWS 8 NOTES TO FINANCIAL STATEMENTS 9 Independent Auditor’s Report Board of Directors and Stockholders Nu |
|
| January 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (IRS. |
|
| January 16, 2025 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On November 1, 2024 (the “Closing Date”), Kewaunee Scientific Corporation (“Kewaunee”, or the “Company”) completed an acquisition (the “Acquisition”) of Nu Aire, Inc. (“Nu Aire”) pursuant to the terms of the Securities Purchase Agreement (the “Purchase Agreement”), dated as of the Closing Date, by and among the |
|
| December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 11, 2024 |
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| December 11, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| November 27, 2024 |
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025 Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| November 27, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| November 1, 2024 |
, between Kewaunee Scientific Corporation and PNC Bank, National Association. (incorporated by refer EX-10.1 Exhibit 10.1 Execution Version Loan Agreement THIS LOAN AGREEMENT (the “Agreement”) is entered into as of November 1, 2024 (the “Effective Date”), between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (the “Borrower”), with an address at 2700 West Front Street, P.O. Box 1842, Statesville, North Carolina 28677, and PNC BANK, NATIONAL ASSOCIATION (the “Bank”), with an address at 47 |
|
| November 1, 2024 |
EX-4.1 Exhibit 4.1 Final Form Exhibit D to SPA THIS PROMISSORY NOTE IS SUBJECT TO THE TERMS OF THAT CERTAIN SUBORDINATION AGREEMENT, DATED AS OF THE DATE HEREOF (AS AMENDED, SUPPLEMENTED OR OTHERWISE MODIFIED IN WRITING FROM TIME TO TIME), BY AND AMONG PNC BANK, NATIONAL ASSOCIATION (“PNC”), KEWAUNEE SCIENTIFIC CORPORATION, AND [NAME OF SELLER] (THE “SUBORDINATION AGREEMENT”). NOTWITHSTANDING ANY |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (IRS. |
|
| November 1, 2024 |
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) March 28, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| November 1, 2024 |
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire EX-99.1 Exhibit 99.1 Kewaunee Scientific Corporation Completes Acquisition of Nu Aire Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. November 1, 2024 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) Kewaunee Scientific Corporation (“Kewaunee”), a leader in laboratory furniture and technical product design and manufacturing, today announced the su |
|
| November 1, 2024 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION SECURITIES PURCHASE AGREEMENT by and among KEWAUNEE SCIENTIFIC CORPORATION, NU AIRE, INC., SELLERS SET FORTH ON THE SIGNATURE PAGES HERETO, and the SELLERS’ REPRESENTATIVE dated November 1, 2024 TABLE OF CONTENTS Page Article I DEFINITIONS 2 Section 1.1 Definitions 2 Article II PURCHASE AND SALE; CLOSING 17 Section 2.1 Purchase and Sale 17 Section 2.2 Purchase |
|
| November 1, 2024 |
EX-10.2 Exhibit 10.2 Final Form THIS AGREEMENT IS SUBJECT TO THE TERMS OF THAT CERTAIN SUBORDINATION AGREEMENT, DATED AS OF THE DATE HEREOF (AS AMENDED, SUPPLEMENTED OR OTHERWISE MODIFIED IN WRITING FROM TIME TO TIME), BY AND AMONG PNC BANK, NATIONAL ASSOCIATION (“PNC”), KEWAUNEE SCIENTIFIC CORPORATION, AND SECURED PARTY (AS DEFINED BELOW) (THE “SUBORDINATION AGREEMENT”). NOTWITHSTANDING ANY CONTR |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| September 11, 2024 |
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| September 11, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| August 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (IRS. |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No. |
|
| August 28, 2024 |
Exhibit 99.1 KEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU Special Note Regarding Forward-Looking Statements Certain statements in this document constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the Reform Act ). All statements other than statements of historical fact included in this Annual Report, including statements regarding the C |
|
| August 28, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| August 28, 2024 |
Kewaunee Scientific Corporation Annual Shareholder Speech August 28, 2024 Exhibit 99.2 KEWAUNEE ANNUAL SHAREHOLDER SPEECH AUGUST 28, 2024 Kewaunee Scientific Corporation Annual Shareholder Speech August 28, 2024 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee’s 2024 annual shareholder meeting. This year’s meeting is again being conducted virtually, providing our shareholders with a more accessi |
|
| August 28, 2024 |
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025 Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| June 28, 2024 |
Incentive-Based Compensation R 317077084.1 KEWAUNEE SCIENTIFIC CORPORATION INCENTIVE-BASED COMPENSATION RECOVERY POLICY EFFECTIVE DECEMBER 1, 2023 1. Policy Purpose. The purpose of this Kewaunee Scientific Corporation (the “Company”) Incentive-Based Compensation Recovery Policy (this “Policy”) is to enable the Company to recover Erroneously Awarded Compensation in the event that the Company is required to prepare an Accounting |
|
| June 28, 2024 |
, 2024, by and between Kewaunee Scientific Corporation and Donald T. Gardner III |
|
| June 28, 2024 |
` Exhibit 21.1 Name of Subsidiary Jurisdiction of Organization Percentage Ownership Kewaunee Labway Asia Pte. Ltd. Singapore 100% Kewaunee Labway India Pvt. Ltd. India 94% Kewaunee Scientific Corporation Singapore Pte. Ltd. Singapore 100% Koncepo Scientech International Pvt. Ltd. India 80% Kequip Global Lab Solutions Pvt. Ltd. India 70% |
|
| June 26, 2024 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| June 12, 2024 |
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report KEWAUNEE SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 2700 West Front Street Statesville, North Carolina 286 |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commis |
|
| March 22, 2024 |
Exhibit 10.1 KEWAUNEE SCIENTIFIC CORPORATION RETENTION BONUS AGREEMENT 1. Retention Bonus Opportunity. The Company is pleased to offer you a cash retention bonus in the amount of $250,000.00 (the “Bonus”), less all applicable deductions and withholdings. The Bonus will be paid to you in a single lump sum within 10 calendar days following the effectiveness of this Retention Bonus Agreement (the “Ef |
|
| March 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commis |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| March 6, 2024 |
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| February 21, 2024 |
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024 Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| February 21, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2024 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| February 9, 2024 |
SC 13G/A 1 kewaunee13ga3-2.htm MINERVA 13GA3 KEWAUNEE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this St |
|
| February 9, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16 )* Kewaunee Scientific Corp (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| December 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 6, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| December 6, 2023 |
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| November 15, 2023 |
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2024 Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2024 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| September 6, 2023 |
Filing Fee Table (filed herewith). Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Kewaunee Scientific Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common Stock, $2. |
|
| September 6, 2023 |
Registration No. 333- As filed with the Securities and Exchange Commission on September 6, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 38-0715562 (State or other jurisdiction of incorporation or organization) |
|
| September 1, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| September 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| September 1, 2023 |
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2024 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2024 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| August 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 25, 2023 |
Kewaunee Scientific Corporation 2023 Omnibus Incentive Plan, as amended Exhibit 10.1 KEWAUNEE SCIENTIFIC CORPORATION, AS AMENDED 2023 OMNIBUS INCENTIVE PLAN Kewaunee Scientific Corporation sets forth herein the terms of its 2023 Omnibus Incentive Plan, as amended. 1. PURPOSE The Plan is intended to enhance the ability of the Company and its Affiliates to attract and retain highly qualified officers, Nonemployee Directors, employees, consultants and advisors, and to mo |
|
| August 23, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 23, 2023 |
Annual Shareholder Meeting Speech August 23, 2023 Exhibit 99.2 ANNUAL SHAREHOLDER SPEECH AUGUST 23, 2023 Annual Shareholder Meeting Speech August 23, 2023 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee’s 2023 annual shareholder meeting. This year’s meeting is again being conducted virtually, providing our shareholders with a more accessible format in which to participat |
|
| August 23, 2023 |
Exhibit 99.1 Annual Shareholder Meeting encouraging new discovery…Worldwide August 23, 2023 Safe Harbor Statement Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this document, including statements regarding t |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 30, 2023 |
exhibit1034b Pre-Approved Defined Contribution Plan – 06/30/2020 PS Plan 42325-1680602680AA 2020 FMR LLC All rights reserved. |
|
| June 30, 2023 |
exhibit211 ` Exhibit 21.1 Name of Subsidiary Jurisdiction of Organization Percentage Ownership Kewaunee Labway Asia Pte. Ltd. Singapore 100% Kewaunee Labway India Pvt. Ltd. India 95% Kewaunee Scientific Corporation Singapore Pte. Ltd. Singapore 100% Koncepo Scientech International Pvt. Ltd. India 80% Kequip Global Lab Solutions Pvt. Ltd. India 70% |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| June 28, 2023 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| May 26, 2023 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2700 West Front Street Statesville, North Carolina 28677 (Addres |
|
| March 10, 2023 |
iibcreditagreement EXECUTION VERSION 5481553v.9 CREDIT AND SECURITY AGREEMENT dated as of December 19, 2022 by and among KEWAUNEE SCIENTIFIC CORPORATION, as Borrower, and MIDCAP FUNDING IV TRUST, as Agent, and THE LENDERS FROM TIME TO TIME PARTY HERETO 5481553v.9 TABLE OF CONTENTS Page ARTICLE 1 - DEFINITIONS.......................................................................................... |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 10, 2023 |
KEQU / Kewaunee Scientific Corporation / Zucker Anita G - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) Anita G. Zucker, as Trustee of The Article 6 Marital Trust c/o The InterTech Group, Inc. 4838 Jenkins Avenue North Charle |
|
| March 8, 2023 |
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2023 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2023 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| March 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2023 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| February 14, 2023 |
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 10, 2023 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15 )* Kewaunee Scientific Corp (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 8, 2022 |
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2023 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2023 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| December 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| September 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| September 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| September 8, 2022 |
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2023 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2023 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| August 29, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 24, 2022 |
Annual Shareholder Meeting Speech August 24, 2022 Exhibit 99.2 Annual Shareholder Meeting Speech August 24, 2022 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee?s 2022 annual shareholder meeting. This year?s meeting is again being conducted virtually, providing our shareholders a more accessible format in which to participate. Before proceeding, the standard message from |
|
| August 24, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 24, 2022 |
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery?Worldwide Exhibit 99. |
|
| July 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 1, 2022 | ||
| July 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| July 1, 2022 | ||
| July 1, 2022 | ||
| June 30, 2022 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| June 30, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| June 6, 2022 |
Letter of FORVIS, LLP, dated June 6, 2022, to the Securities and Exchange Commission. Exhibit 16.1 June 6, 2022 U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated June 6, 2022 of Kewaunee Scientific Corporation and are in agreement with the statements therein concerning Dixon Hughes Goodman LLP, BKD, LLP and FORVIS, LLP. We have no basis to agree or disagree with other statements of the regist |
|
| June 6, 2022 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commissi |
|
| June 2, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commissi |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commissi |
|
| May 16, 2022 |
KEQU / Kewaunee Scientific Corporation / Kamin Peter Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 Par Value (Title of Class of Securities) 492854104 (CUSIP Number) Peter H. Kamin 2720 Donald Ross Road, #311 Palm Beach Gardens, FL 33410 (Name, Address and Telephone Number of Person Au |
|
| May 10, 2022 |
Youâve Exceeded the SECâs Traffic Limit U.S. Securities and Exchange Commission Youâve Exceeded the SECâs Traffic Limit Your request rate has exceeded the SECâs maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2700 West Front Street Statesville, North Carolina 28677 (Address o |
|
| May 4, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commis |
|
| March 30, 2022 |
Amendment 4 to the Agreement for Purchase and Sale of Real Property, dated March 23, 2022. Exhibit 10.5 FOURTH AMENDMENT TO PURCHASE AGREEMENT This Fourth Amendment to Purchase Agreement (this ?Amendment?) is dated March 23, 2022 (the ?Effective Date?), by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (?Seller?) and CAI INVESTMENTS SUB SERIES 100, LLC, a Nevada limited liability company, and/or its permitted assignee (?Buyer?). RECITALS WHEREAS, Buyer and Seller en |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commis |
|
| March 11, 2022 | ||
| March 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 11, 2022 |
First Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 21, 2022 |
|
| March 11, 2022 |
02720-001/00345989-5 AGREEMENT FOR PURCHASE AND SALE OF REAL PROPERTY THIS AGREEMENT FOR PURCHASE AND SALE OF REAL PROPERTY (this ?Agreement?) is made as of December 22, 2021 (the last date of execution of this Agreement by Buyer and Seller being the ?Effective Date?), by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (?Seller?), and CAI INVESTMENTS SUB SERIES 100, LLC, a Nevada limited liability company (?Buyer?). |
|
| March 11, 2022 |
Third Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 26, 2022 |
|
| March 11, 2022 |
EX-10.1 2 finalkewauneeexecutives.htm EX-10.1 |
|
| March 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2022 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| March 10, 2022 |
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2022 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14 )* Kewaunee Scientific Corp (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| January 25, 2022 |
KEQU / Kewaunee Scientific Corporation / Kamin Peter Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 Par Value (Title of Class of Securities) 492854104 (CUSIP Number) Peter H. Kamin 2720 Donald Ross Road, #311 Palm Beach Gardens, FL 33410 (Name, Address and Telephone Number of Person Aut |
|
| December 23, 2021 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 17, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| December 17, 2021 |
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2022 Exhibit 99.1 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. December 16, 2021 ? PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2021. Fiscal Year 2022 Second Quarter Results: Sales during the second quarter of |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-05286 CUSIP NUMBER: 492854104 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: October 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period Ended: Read Instructions (on back page) Before Preparing Form. |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Comm |
|
| September 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| September 10, 2021 |
Twelfth Amendment to Credit and Security Agreement dated as of July 30, 2021. CHAR2\2444756v7 TWELFTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT This TWELFTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this ?Amendment?), dated as of July 30, 2021, is entered into by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (the ?Borrower?), and WELLS FARGO BANK, NATIONAL ASSOCIATION (the ?Bank?). |
|
| September 9, 2021 |
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2022 Exhibit 99.1 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. September 8, 2021 ? PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2021. Fiscal Year 2022 First Quarter Results: Sales during the first quarter of fiscal |
|
| September 9, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| August 27, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 25, 2021 |
Kewaunee Scientific Corporation Investor Presentation Exhibit 99.1 |
|
| August 25, 2021 |
Kewaunee Scientific Corporation Investor Presentation Script Exhibit 99.2 |
|
| August 25, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| August 13, 2021 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commiss |
|
| July 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 15, 2021 | ||
| July 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| July 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 9, 2021 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exhibit 99.1 Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. July 8, 2021 ? PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2021. Fiscal Year 2021 Fourth Quarter Results: Sales during the fourth q |
|
| July 9, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commissi |
|
| June 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Kewaunee Scientific Corporation (Name of Issuer) Common Stock, $2.50 par value (Title of Class of Securities) 492854104 (CUSIP Number) June 3, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| May 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2700 West Front Street Statesville, North Carolina 28677 (Address o |
|
| May 10, 2021 |
EX-1.01 2 d173250dex101.htm EX-1.01 Exhibit 1.01 Conflict Minerals Disclosure for the Year Ended December 31, 2020 This Conflict Minerals Disclosure (“Disclosure”) of Kewaunee Scientific Corporation has been prepared for the period from January 1, 2020 to December 31, 2020. With respect to the year ended December 31, 2020, we identified several products for which 3TGs (as defined below) may be pre |
|
| April 29, 2021 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| March 12, 2021 | ||
| March 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 11, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commis |
|
| March 11, 2021 |
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2021 EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. March 10, 2021 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its third quarter of fiscal year 2021, ended January 31, 2021. Sales for the quarter were $33,339,000, a 2.6% dec |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13 )* Kewaunee Scientific Corp (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| January 29, 2021 |
Entry into a Material Definitive Agreement - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2021 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) ( |
|
| December 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 10, 2020 |
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2021 EX-99.1 2 d35570dex991.htm EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. December 9, 2020 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter of fiscal year 2021, ended October 31, 2020. Sales for the quart |
|
| December 10, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Comm |
|
| September 11, 2020 |
changeofcontrolbatdorffa |
|
| September 11, 2020 |
kewauneesignedninthamf82 |
|
| September 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| September 9, 2020 |
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2021 EX-99.1 2 d10545dex991.htm EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. September 8, 2020 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its first quarter of fiscal year 2021, ended July 31, 2020. Sales for the quarter w |
|
| September 9, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) |
|
| August 28, 2020 |
Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (C |
|
| August 26, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (C |
|
| August 26, 2020 |
EX-99.1 Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide Exhibit 99.1 Special Note Regarding Forward-Looking Statements Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this docu |
|
| July 29, 2020 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 27, 2020 |
kewauneesignedninthamend |
|
| July 27, 2020 |
Letter of Ernst & Young LLP dated July 27, 2020 eyletter Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated July 27, 2020, of Kewaunee Scientific Corporation and are in agreement with the statements contained in the Item 4.01(a) on pages 2-3 therein. We have no basis to agree or disagree with other statements of the registrant contained therein. In addition, |
|
| July 27, 2020 |
Offer Letter dated as of May 7, 2020 between Kewaunee Scientific Corporation and Douglas J. Batdorff EX-10.85 2 dougbatdorffofferletter.htm EXHIBIT 10.85 |
|
| July 27, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| July 27, 2020 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No. |
|
| July 27, 2020 |
changeofcontrolbatdorff |
|
| July 27, 2020 |
exhibit21 ` Exhibit 21.1 Name of Subsidiary Jurisdiction of Organization Percentage Ownership Kewaunee Labway Asia Pte. Ltd. Singapore 100% Kewaunee Labway India Pvt. Ltd. India 95% Kewaunee Scientific Corporation Singapore Pte. Ltd. Singapore 100% Kewaunee Scientific (Suzhou) Co., Ltd. China 100% Koncepo Scientech International Pvt. Ltd. India 80% Kequip Global Lab Solutions Pvt. Ltd. India 70% |
|
| July 24, 2020 |
EX-10.1 Exhibit 10.1 NINTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT, FIFTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE AND WAIVER This NINTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT, FIFTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE AND WAIVER (this “Amendment”), dated as of July 20, 2020, is entered into by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (the “Borrower”), an |
|
| July 24, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| July 22, 2020 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| July 22, 2020 |
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter EX-99.1 2 d908433dex991.htm EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. July 21, 2020 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2020. Fiscal Year 2020 Fourth Quart |
|
| July 22, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| July 22, 2020 |
EX-99.1 Exhibit 99.1 Kewaunee Scientific Corporation Accelerates Growth in The Middle East & Africa Market by establishing a Local Entity in Saudi Arabia Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704-871-3290 Statesville, N.C. – July 21, 2020 – Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and t |
|
| June 1, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) |
|
| June 1, 2020 |
Kewaunee Scientific Announces the Appointment of a New Vice President of Manufacturing Operations EX-99.1 Exhibit 99.1 Kewaunee Scientific Announces the Appointment of a New Vice President of Manufacturing Operations Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704-871-3274 STATESVILLE, N.C. June 1, 2020 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Douglas J. Batdorff has joined the Company as Vice President of Manufacturing Operations. Mr. Batdor |
|
| May 18, 2020 |
Termination of a Material Definitive Agreement 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Comm |
|
| May 11, 2020 |
EX-1.01 Exhibit 1.01 Conflict Minerals Disclosure for the Year Ended December 31, 2019 This Conflict Minerals Disclosure (“Disclosure”) of Kewaunee Scientific Corporation has been prepared for the period from January 1, 2019 to December 31, 2019. With respect to the year ended December 31, 2019, we identified several products for which 3TGs (as defined below) may be present in and necessary to the |
|
| May 11, 2020 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2700 West Front Street Statesville, North Carolina 28677 (Addres |
|
| May 7, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Commi |
|
| April 27, 2020 |
EX-3 Exhibit 3 KEWAUNEE SCIENTIFIC CORPORATION (a Delaware corporation) Bylaws (as amended April 21, 2020) ARTICLE I OFFICES Section 1. |
|
| April 27, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Co |
|
| April 13, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| March 24, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Co |
|
| March 13, 2020 |
first401kadmendment |
|
| March 13, 2020 |
changeofcontroldocforman |
|
| March 13, 2020 |
ex101 12/16/2019 EX-10.1 EX-10.1 2 d846452dex101.htm EX-10.1 Exhibit 10.1 Execution Version EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE This EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE (this “Amendment”), dated as of December 13, 2019 (the “Eighth Amendment Effective Date”), is e |
|
| March 13, 2020 |
KEQU / Kewaunee Scientific Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| March 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2020 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Com |
|
| March 4, 2020 |
Kewaunee Scientific Reports Results for Third Quarter EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for Third Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. March 3, 2020 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its third quarter of fiscal year 2020, ended January 31, 2020. Sales for the quarter were $34,225,000, a 5.7% increase from sales of $ |
|
| February 12, 2020 |
KEQU / Kewaunee Scientific Corp. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* KEWAUNEE SCIENTIFIC CP (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Kewaunee Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| January 29, 2020 |
KEQU / Kewaunee Scientific Corp. / Wellington Trust Co NA - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Kewaunee Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| January 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Kewaunee Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| December 16, 2019 |
KEQU / Kewaunee Scientific Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CO |
|
| December 16, 2019 |
Kewaunee Scientific Reports Results for Second Quarter, Suspension of Dividend EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for Second Quarter, Suspension of Dividend Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. December 16, 2019 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter of fiscal year 2020, ended October 31, 2019. Sales for the quarter were $39,722,000, a |
|
| December 16, 2019 |
EX-10.1 2 d846452dex101.htm EX-10.1 Exhibit 10.1 Execution Version EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE This EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE (this “Amendment”), dated as of December 13, 2019 (the “Eighth Amendment Effective Date”), is entered into by and betwee |
|
| December 16, 2019 |
ex101 12/16/2019 EX-10.1 EX-10.1 2 d846452dex101.htm EX-10.1 Exhibit 10.1 Execution Version EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE This EIGHTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT NOTE (this “Amendment”), dated as of December 13, 2019 (the “Eighth Amendment Effective Date”), is e |
|
| December 16, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) |
|
| December 16, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) |
|
| December 16, 2019 |
offerlettermandarranade1 October 28, 2019 Mr. Mandar Ranade [email protected] Dear Mandar, I am pleased to confirm our offer of employment with Kewaunee Scientific Corporation as our Vice President of Information Technology, reporting to Tom Hull, President and CEO. In this position, your starting salary will be $17,500 monthly ($210,000.00 annualized). Following our normal practices, this offe |
|
| November 27, 2019 |
EX-99.1 Exhibit 99.1 Kewaunee Scientific Announces Release Date to Report Results for Second Quarter Fiscal Year 2020 And Quarterly Dividend Announcement STATESVILLE, N.C., Nov. 26, 2019 /PRNewswire/ — Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its second quarter fiscal year 2020 financial results and quarterly dividend announcement on Monday, |
|
| November 27, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporat |
|
| October 30, 2019 |
KEQU / Kewaunee Scientific Corp. / Zucker Anita G - SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Kewaunee Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 492854104 (CUSIP Number) Anita G. Zucker, as Trustee of The Article 6 Marital Trust c/o The InterTech Group, Inc. 4838 Jenkins Avenue North Charleston, SC 29405 (843) 744-5174 ( |
|
| September 6, 2019 |
KEQU / Kewaunee Scientific Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPO |
|
| August 30, 2019 |
Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporatio |
|
| August 28, 2019 |
Kewaunee Scientific Corporation 2019 Shareholder Speech Transcript – August 28, 2019 EX-99.2 Exhibit 99.2 Kewaunee Scientific Corporation 2019 Shareholder Speech Transcript – August 28, 2019 Good morning. I would like to extend a warm welcome to our shareholders who have set aside time to join us today at Kewaunee’s 2019 annual shareholder meeting. Before proceeding, the standard message from our attorneys. From an agenda perspective, I will be sharing with you highlights from our |
|
| August 28, 2019 |
EX-99.1 Exhibit 99.1 Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide 1 1Exhibit 99.1 Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide 1 1 Special Note Regarding Forward-Looking Statements Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1 |
|
| August 28, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (C |
|
| August 28, 2019 |
Kewaunee Scientific Reports Results for First Quarter EX-99.1 Exhibit 99.1 Kewaunee Scientific Reports Results for First Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. August 27, 2019 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its first quarter of fiscal year 2020, ended July 31, 2019. Sales for the quarter were $39,336,000, a 6.7% decrease from sales of $4 |
|
| August 28, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (C |
|
| July 19, 2019 |
KEQU / Kewaunee Scientific Corp. DEF 14A - - DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 11, 2019 |
Entry into a Material Definitive Agreement 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Comm |
|
| July 11, 2019 |
Sixth Amendment to Credit and Security Agreement dated as of May 28, 2019. Exhibit 10.61F SIXTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT This SIXTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this “Amendment”), dated as of May 28, 2019 (the “Sixth Amendment Effective Date”), is entered into by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (the “Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (the “Bank”). W I T N E S S E T H: WHEREAS, the B |
|
| July 11, 2019 |
EXHIBIT 10.61I SECURITY AGREEMENT 1. GRANT OF SECURITY INTEREST. For valuable consideration, the undersigned KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation ("Debtor"), hereby grants and transfers to WELLS FARGO BANK, NATIONAL ASSOCIATION ("Bank") a security interest in all of the property of Debtor described as follows: (a) all accounts, deposit accounts, contract rights, chattel paper, ( |
|
| July 11, 2019 |
KEQU / Kewaunee Scientific Corp. 10-K - Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-5286 KEWAUNEE SCIEN |
|
| July 11, 2019 |
EX-4.1 2 exhibit41.htm EXHIBIT 4.1 EXHIBIT 4.1 KEWAUNEE SCIENTIFIC CORPORATION DESCRIPTION OF CAPITAL STOCK The following describes the common stock and certain provisions of the Restated Certificate of Incorporation (the “Certificate of Incorporation”) and Amended By-Laws (the “By-Laws”) of Kewaunee Scientific Corporation (the “Company”). This description is only a summary and is qualified in its |
|
| July 11, 2019 |
EX-21.1 9 exhibit211.htm EXHIBIT 21.1 ` Exhibit 21.1 Name of Subsidiary Jurisdiction of Organization Percentage Ownership Kewaunee Labway Asia Pte. Ltd. Singapore 100 % Kewaunee Labway India Pvt. Ltd. India 95 % Kewaunee Scientific Corporation Singapore Pte. Ltd. Singapore 100 % Kewaunee Scientific (Suzhou) Co., Ltd. China 100 % Koncepo Scientech International Pvt. Ltd. India 80 % Kequip Global La |
|
| July 11, 2019 |
Fifth Amendment to Credit and Security Agreement dated as of April 22, 2019 Exhibit 10.61E FIFTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT This FIFTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this “Amendment”), dated as of April 22, 2019 (the “Fifth Amendment Effective Date”), is entered into by and between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation (the “Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (the “Bank”). W I T N E S S E T H: WHEREAS, the |
|
| July 11, 2019 |
EX-10.61G 6 exhibit1061g.htm EXHIBIT 10.61G Exhibit 10.61G SEVENTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND THIRD AMENDMENT TO REVOLVING LINE OF CREDIT NOTE This SEVENTH AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND THIRD AMENDMENT TO REVOLVING LINE OF CREDIT NOTE (this “Amendment”), dated as of July 9, 2019 (the “Seventh Amendment Effective Date”), is entered into by and between KEWAUNEE S |
|
| July 11, 2019 |
EXHIBIT 10.61H June 19, 2019 KEWAUNEE SCIENTIFIC CORPORATION P.O. Box 1842 Statesville, North Carolina 28687 Attention: Thomas D. Hull III Re: Credit and Security Agreement between KEWAUNEE SCIENTIFIC CORPORATION, a Delaware corporation ("Borrower"), and WELLS FARGO BANK, NATIONAL ASSOCIATION ("Bank"), dated as of May 6, 2013, as the same may be amended from time to time (the "Credit Agreement") D |
|
| July 11, 2019 |
Kewaunee Scientific Corporation EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into as of October 18, 2017 (the “Effective Date”), by and between Bhoopathy Sathymurthy (“Executive”) and Kewaunee Labway India Pvt. |
|
| June 21, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2019 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction of incorporation) (Co |
|
| June 21, 2019 |
EX-10.1 2 d722103dex101.htm EX-10.1 Exhibit 10.1 SEPARATION AGREEMENT This SEPARATION AGREEMENT (“Agreement”) is made and entered into by and between David M. Rausch (“Employee”) and Kewaunee Scientific Corporation (“Company”). WHEREAS, Employee is currently employed by Company as an at-will employee; WHEREAS, Employee has decided to resign from employment with Company, and Company has accepted Em |
|
| June 21, 2019 |
EX-10.4 Exhibit 10.4 CHANGE OF CONTROL EMPLOYMENT AGREEMENT AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware corporation (the “Company”) and Kurt P. Rindoks (the “Executive”), effective as of the 18th day of June 2019. The Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to ensure that the Compan |
|
| June 21, 2019 |
EX-10.3 Exhibit 10.3 CHANGE OF CONTROL EMPLOYMENT AGREEMENT AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware corporation (the “Company”) and Michael G. Rok (the “Executive”), effective as of the 18th day of June 2019. The Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to ensure that the Company |
